Napa Wealth Management lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 52.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,951 shares of the healthcare conglomerate’s stock after selling 2,141 shares during the period. Napa Wealth Management’s holdings in UnitedHealth Group were worth $987,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently modified their holdings of UNH. NewSquare Capital LLC purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $26,000. Hurley Capital LLC purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $28,000. AlphaMark Advisors LLC purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $30,000. Finally, Aster Capital Management DIFC Ltd purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $30,000. Institutional investors own 87.86% of the company’s stock.
Analysts Set New Price Targets
A number of equities analysts have commented on the stock. Truist Financial cut their price target on shares of UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating for the company in a research note on Monday, April 21st. Royal Bank of Canada cut their price target on shares of UnitedHealth Group from $655.00 to $525.00 and set an “outperform” rating for the company in a research note on Wednesday, April 23rd. Hsbc Global Res cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 22nd. KeyCorp cut their price target on shares of UnitedHealth Group from $650.00 to $575.00 and set an “overweight” rating for the company in a research note on Monday, April 21st. Finally, Morgan Stanley lowered their price objective on shares of UnitedHealth Group from $664.00 to $563.00 and set an “overweight” rating for the company in a report on Tuesday, April 22nd. Four investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $596.86.
UnitedHealth Group Stock Down 0.6%
Shares of NYSE UNH opened at $378.42 on Tuesday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $347.04 and a 12 month high of $630.73. The firm has a market capitalization of $343.28 billion, a PE ratio of 24.41, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The firm has a fifty day simple moving average of $486.06 and a two-hundred day simple moving average of $520.74.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter last year, the company posted $6.91 earnings per share. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.22%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is presently 35.18%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
- Five stocks we like better than UnitedHealth Group
- What is the Nasdaq? Complete Overview with History
- Palantir’s Latest Deal Could Put a Freeze on Its Stock Price
- Comparing and Trading High PE Ratio Stocks
- 4 Automaker Stocks React to Tariffs: Winners and Losers
- What is a Secondary Public Offering? What Investors Need to Know
- Here’s Why Call Option Traders Love Dutch Bros Stock
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.